<p>(A) Interventional clinical trials for NDs: analysis of completed trials and (B) those recruiting patients.</p
Clinical characteristics and treatment outcomes for patients in the two treatment arms.</p
<p>Enrollment, randomization, follow-up, and inclusion in the final analysis in the study comparing ...
<p>Enrollment, randomization, withdrawals, and completion of the 2 treatment phases (n = 11).</p
<p>* Net of trials where the phase is not specified.</p><p>Distribution of interventional clinical t...
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
<p>Key findings and operational insights from the study relevant to NTD intervention planning and im...
Synthesis of results from controlled studies evaluating interventions targeting patients.</p
<p>Types of phase 1 clinical trials in which cases and controls were included.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
Characteristics of clinical trials of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy....
<p>Clinical trial design describing the three different treatment sequences and the wash-out period....
Following the completion of Phase I trials, an investigational drug can move into Phase II trials, a...
Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were includ...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Baseline characteristics of patients by group of analysis (part 2): Actual intervention among multi-...
Clinical characteristics and treatment outcomes for patients in the two treatment arms.</p
<p>Enrollment, randomization, follow-up, and inclusion in the final analysis in the study comparing ...
<p>Enrollment, randomization, withdrawals, and completion of the 2 treatment phases (n = 11).</p
<p>* Net of trials where the phase is not specified.</p><p>Distribution of interventional clinical t...
<p>Interventions compared, study objectives and main study conclusions of included studies.</p
<p>Key findings and operational insights from the study relevant to NTD intervention planning and im...
Synthesis of results from controlled studies evaluating interventions targeting patients.</p
<p>Types of phase 1 clinical trials in which cases and controls were included.</p
<p>Enrollment, attrition, drug treatments, and outcomes of patients in all samples.</p
Characteristics of clinical trials of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy....
<p>Clinical trial design describing the three different treatment sequences and the wash-out period....
Following the completion of Phase I trials, an investigational drug can move into Phase II trials, a...
Flow diagram of patients enrolled in the TrEAT TD clinical trial and paired samples that were includ...
<p>Treatments administered by each study and respective study characteristics for included efficacy ...
Baseline characteristics of patients by group of analysis (part 2): Actual intervention among multi-...
Clinical characteristics and treatment outcomes for patients in the two treatment arms.</p
<p>Enrollment, randomization, follow-up, and inclusion in the final analysis in the study comparing ...
<p>Enrollment, randomization, withdrawals, and completion of the 2 treatment phases (n = 11).</p
DOI
Add to ORKG